BioSpace News Archive

Business

Artelo Biosciences Reports Four-Month 2021 Financial Results in Connection with its Amended Fiscal Year End and Provides Business Update

Artelo Biosciences, Inc. today reported financial and operating results for the four month transitional period from September 1, 2021 to December 31, 2021 and provided a business update.

March 21, 2022
·
6 min read
Pharm Country

ContraFect to Present at the Maxim Group 2022 Virtual Growth Conference

ContraFect Corporation announces today that Roger Pomerantz, M.D., President, Chief Executive Officer and Chairman of ContraFect, will participate in a fireside chat at the Maxim Group 2022 Virtual Growth Conference, which is being held virtually from March 28–30, 2022.

March 21, 2022
·
4 min read
Business

Graphite Bio Reports Recent Business Progress and Fourth Quarter and Fiscal Year 2021 Financial Results

Graphite Bio today reported recent business progress and fourth quarter and fiscal year 2021 financial results.

March 21, 2022
·
12 min read
FDA

NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS

NeuroSense Therapeutics Ltd. today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.

March 21, 2022
·
5 min read
Drug Development

Evommune Initiates Phase 1 Study to Evaluate Safety of EVO101, an IRAK4 Inhibitor, in Healthy Volunteers

Evommune, Inc., a clinical-stage biotechnology company dedicated to the development of transformative medicines for inflammatory diseases, today announced enrollment of the first participant in its Phase 1 study of EVO101 in healthy volunteers.

March 21, 2022
·
2 min read
BioMidwest

Integrated DNA Technologies Adds MLL Munich Leukemia Laboratory to Align Program

On the heels of Integrated DNA Technologies’ xGen™ NGS portfolio launch in December, MLL, the Munich Leukemia Laboratory, one of the leading research and diagnostic laboratories for leukemias and lymphomas, has joined the global genomics solutions provider’s Align Program.

March 21, 2022
·
5 min read
Business

Taconic Biosciences Improves rasH2 Carcinogenicity Test System Access in Asia-Pacific RegionFour-way distribution partnership provides quality, consistent rasH2 supply to India and China, better serving global customers

Taconic Biosciences has appointed Nomura Siam International Co., Ltd. (NSI) and Nomura Jimusho. Inc. (NJI) as sales agents and distributors of the rasH2 Mouse Carcinogenicity Test System in India and China, respectively.

March 21, 2022
·
4 min read
Business

Vivacitas Oncology Appoints Harvard Professor of Medicine Dr. David Reardon, MD to the Company’s Neuro-Oncology Medical Advisory Board

Vivacitas Oncology, Inc. is honored to welcome, Dr. David Reardon, MD, Professor of Medicine at Harvard Medical School and Clinical Director for Dana-Farber Cancer Institute, Center for Neuro-Oncology as a new member of its top-tier Neuro-Oncology Advisory Board.

March 21, 2022
·
3 min read
Biond Biologics Announces Oral Presentation for BND-67, an Inhibitor of CD28 Shedding, a Potential Novel Resistance Mechanism to Anti PD-1 Therapy, at the American Association for Cancer Research (AACR) 2022 Annual Meeting

Biond Biologics Ltd., announced today that the abstract on BND-67 was accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting, taking place on April 8 - 13, 2022, in New Orleans, Louisiana.

March 21, 2022
·
4 min read
Genetown

ZOLL Launches Next Generation MCT Solution, Shown to Improve Patient Management Decisions in Largest Ever MCT Trial

ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the launch of the ZOLL Arrhythmia Management System.

March 21, 2022
·
4 min read